Late-Onset Clozapine-Induced Agranulocytosis in a Young Woman with Paranoid Schizophrenia

Treatment of schizophrenia has taken so many turns, and adverse effects of the drugs still continue to remain as a hurdle in the management. Clozapine is considered to be the better promising drug in the treatment of paranoid schizophrenia with minimal side effects. Clozapine-induced agranulocytosis...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmacology & pharmacotherapeutics Vol. 11; no. 4; pp. 140 - 141
Main Authors: Vinayaka, Anuhya, Sheshadri, Shubha, Madhyastha, Sharath P., Shetty, Ganesh V., Reddy, Charan Thej
Format: Journal Article
Language:English
Published: New Delhi, India SAGE Publications 01-10-2020
Wolters Kluwer India Pvt. Ltd
Medknow Publications and Media Pvt. Ltd
Sage Publications Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Treatment of schizophrenia has taken so many turns, and adverse effects of the drugs still continue to remain as a hurdle in the management. Clozapine is considered to be the better promising drug in the treatment of paranoid schizophrenia with minimal side effects. Clozapine-induced agranulocytosis is one adverse event that troubles clinicians, and it requires a vigilant eye to look for the signs. In the present study, the authors discuss a case which has developed agranulocytosis in the later stages of clozapine treatment.
ISSN:0976-500X
0976-5018
DOI:10.4103/jpp.JPP_29_20